Upgrade to SI Premium - Free Trial

Veracyte (VCYT)

40.98 -0.23 (0.56%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/10/26)

Latest Headlines

Needham Reiterates Buy Rating on Veracyte, Inc (VCYT) September 15, 2026 5:22 AM - StreetInsider Form 144 VERACYTE, INC. Filed by: Holstein Jens September 14, 2026 5:01 PM - SEC Filing Form 8-K VERACYTE, INC. For: Sep 10 September 14, 2026 4:08 PM - SEC Filing Veracyte acquires Convergent Genomics for up to $180M September 14, 2026 4:05 PM - StreetInsider Veracyte Acquires Convergent Genomics, Expanding its Urology Diagnostics Portfolio with a Urinary Tumor DNA Testing Platform September 14, 2026 4:05 PM - StreetInsider Form 4 VERACYTE, INC. For: Sep 02 Filed by: Wygant Jonathan September 11, 2026 11:36 AM - SEC Filing Form 4 VERACYTE, INC. For: Sep 02 Filed by: Stapley Marc September 11, 2026 11:36 AM - SEC Filing Form 4 VERACYTE, INC. For: Sep 02 Filed by: Leite John September 11, 2026 11:36 AM - SEC Filing Form 4 VERACYTE, INC. For: Sep 02 Filed by: McGuire Annie September 11, 2026 11:36 AM - SEC Filing Form 4 VERACYTE, INC. For: Sep 02 Filed by: Febbo Phillip G. September 11, 2026 11:35 AM - SEC Filing Form 4 VERACYTE, INC. For: Sep 02 Filed by: Chambers Rebecca September 11, 2026 11:35 AM - SEC Filing Veracyte, Inc (VCYT) PT Raised to $65 at UBS September 9, 2026 9:07 AM - StreetInsider Veracyte to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference September 1, 2026 4:05 PM - StreetInsider Veracyte, Inc (VCYT) PT Lowered to $44 at Morgan Stanley August 4, 2026 8:13 AM - StreetInsider Veracyte, Inc (VCYT) PT Lowered to $55 at Stephens August 4, 2026 7:29 AM - StreetInsider Veracyte, Inc (VCYT) PT Lowered to $54 at Piper Sandler August 4, 2026 6:55 AM - StreetInsider Veracyte, Inc (VCYT) PT Lowered to $50 at Canaccord August 3, 2026 5:50 AM - StreetInsider Form 10-Q VERACYTE, INC. For: Jun 30 July 31, 2026 4:12 PM - SEC Filing Veracyte, Inc (VCYT) PT Raised to $66 at Freedom Capital July 31, 2026 6:21 AM - StreetInsider Veracyte, Inc (VCYT) PT Raised to $69 at Needham July 31, 2026 5:08 AM - StreetInsider Veracyte (VCYT) Tops Q2 EPS by 11c; Offers Guidance July 30, 2026 4:30 PM - StreetInsider Form 8-K VERACYTE, INC. For: Jul 30 July 30, 2026 4:19 PM - SEC Filing Veracyte Announces Second Quarter 2026 Financial Results July 30, 2026 4:05 PM - Globe NewsWire Veracyte to Participate in Upcoming Investor Conferences July 28, 2026 4:05 PM - StreetInsider Piper Sandler Starts Veracyte, Inc (VCYT) at Overweight July 15, 2026 4:09 AM - StreetInsider Veracyte, Inc (VCYT) PT Raised to $60 at Canaccord July 14, 2026 6:42 AM - StreetInsider Veracyte to Release Second Quarter 2026 Financial Results on July 30, 2026 July 9, 2026 4:05 PM - BizWire Veracyte, Inc (VCYT) PT Raised to $47 at Morgan Stanley July 9, 2026 8:16 AM - StreetInsider Veracyte, Inc (VCYT) PT Raised to $65 at Guggenheim June 29, 2026 6:55 AM - StreetInsider Form 4 VERACYTE, INC. For: Jun 18 Filed by: EASTHAM KARIN June 22, 2026 4:31 PM - SEC Filing Form 144 VERACYTE, INC. Filed by: EASTHAM KARIN June 18, 2026 4:23 PM - SEC Filing Full Article List